切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2025, Vol. 18 ›› Issue (01) : 15 -22. doi: 10.3877/cma.j.issn.1674-6902.2025.01.003

论著

多西环素联合左氧氟沙星治疗鲍曼不动杆菌肺炎
庞茜茜1, 刘云宁1, 刘斐1, 赵学萍1, 胡亚丽1, 刘克勤1,   
  1. 1. 075000 张家口,河北北方学院附属第一医院药学部
  • 收稿日期:2024-10-12 出版日期:2025-02-25
  • 通信作者: 刘克勤
  • 基金资助:
    河北省卫健委医学科学课题研究计划(20231455)北京医卫健康公益基金会医学科学研究基金资助项目(ZL007HB)

Clinical analysis of doxycycline combined with levofloxacin for the treatment of Acinetobacter Baumannii pneumonia

Qianqian Pang1, Yunning Liu1, Fei Liu1, Xueping Zhao1, Yali Hu1, Keqin Liu1,   

  1. 1. Department of Pharmacy, The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China
  • Received:2024-10-12 Published:2025-02-25
  • Corresponding author: Keqin Liu
引用本文:

庞茜茜, 刘云宁, 刘斐, 赵学萍, 胡亚丽, 刘克勤. 多西环素联合左氧氟沙星治疗鲍曼不动杆菌肺炎[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(01): 15-22.

Qianqian Pang, Yunning Liu, Fei Liu, Xueping Zhao, Yali Hu, Keqin Liu. Clinical analysis of doxycycline combined with levofloxacin for the treatment of Acinetobacter Baumannii pneumonia[J/OL]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(01): 15-22.

目的

分析多西环素联合左氧氟沙星调控高温需求因子A2(high temperature requirement factor A2,HtrA2)治疗耐碳青霉烯类鲍曼不动杆菌(Carbapenem-resistant Acinetobacter Baumannii,CRAB)肺炎的机制。

方法

选择60 只SD 大鼠,随机分为对照组、模型组、多西环素组、左氧氟沙星组、联合组、过表达(overexpressed,oe)-HtrA2 组,每组10 只。 模型组使用100 μl 1×1011 cfu/L AB5075 菌液滴入大鼠鼻腔;多西环素组在模型组基础上使用20 mg/kg 多西环素灌胃给药;左氧氟沙星组在模型组基础上使用30 mg/kg 左氧氟沙星灌胃给药;联合组在模型组基础上使用20 mg/kg 多西环素+30 mg/kg 左氧氟沙星混合灌胃给药;oe-HtrA2 组采用HtrA2 慢病毒经尾静脉注射SD 大鼠体内,每次200 μl 1×109 IFU/L。 采用实时荧光定量聚合酶链反应检测HtrA2 mRNA 表达;采用菌落形成单位法检测肺组织细菌含量;采用试剂盒检测白细胞计数和中性粒细胞百分比、炎症因子及氧化应激水平;采用蛋白印迹法检测Toll 样受体(Toll-like receptor,TLR)信号通路相关蛋白水平。

结果

对照组、模型组、多西环素组、左氧氟沙星组、联合组和oe-HtrA2 组的HtrA2 mRNA 表达分别为(1.00±0.16)、(2.31±0.29)、(1.76±0.17)、(1.81±0.26)、(1.37±0.14)和(3.89±0.58),TLR2 蛋白水平分别为(1.00±0.20)、(3.65±0.60)、(2.88±0.43)、(2.74±0.65)、(1.87±0.21)和(2.92±0.49),TLR4 蛋白水平分别为(1.00±0.17)、(3.92±0.71)、(2.77±0.54)、(2.81±0.43)、(2.06±0.28)和(3.11±0.44),髓样分化因子88(myeloid differentiation factor 88,MyD88)蛋白水平分别为(1.00±0.15)、(2.94±0.45)、(2.21±0.39)、(2.25±0.23)、(1.44±0.16)和(2.41±0.27)(P<0.05)。 多西环素组和左氧氟沙星组HtrA2 表达、白细胞计数及中性粒细胞百分比、炎症及氧化应激水平、TLR 信号通路蛋白水平低于模型组,高于联合组; oe-HtrA2 组与联合组结果相反。

结论

多西环素联合左氧氟沙星改善CRAB 肺炎大鼠肺部损伤,与调控HtrA2 抑制TLR2/4-MyD88 信号通路激活相关。

Objective

To study the mechanism of doxycycline combined with levofloxacin in regulating high temperature requirement factor A2 (HtrA2) for the treatment of rats with pneumonia caused by Carbapenem-resistant Acinetobacter Baumannii(CRAB).

Methods

Sixty SD rats were randomly divided into control group,model group,doxycycline group,levofloxacin group,combination group and overexpressed(oe)-HtrA2 group,with 10 rats in each group.In the model group,100 μl 1×1011 cfu/L AB5075 bacteria were dropped into the nasal cavity of rats; Doxycycline group was given 20 mg/kg doxycycline intragastric administration on the basis of model group.Levofloxacin group was given 30 mg/kg levofloxacin by gavage on the basis of model group.Based on the model group,the combined group was given 20 mg/kg doxycycline +30 mg/kg levofloxacin by intragastric administration;In group oe-HtrA2,HtrA2 lentivirus was injected into SD rats through the tail vein at 200 μl and 1×109 IFU/L each time.Real-time fluorescence quantitative polymerase chain reaction was used to detect the expression of HtrA2 mRNA.The colony-forming unit method was employed to measure the bacterial content in lung tissues.Kits were utilized to detect white blood cell count,the percentage of neutrophils,the levels of inflammatory factors and oxidative stress.Western blotting was adopted to detect the levels of proteins related to the Toll-like receptor (TLR) signaling pathway.

Results

The expressions of HtrA2 mRNA in the control group,model group,doxycycline group,levofloxacin group,combination group and oe-HtrA2 group were (1.00±0.16),(2.31±0.29),(1.76±0.17),(1.81±0.26),(1.37±0.14) and (3.89±0.58) respectively.The protein levels of TLR2 in these groups were (1.00±0.20),(3.65±0.60),(2.88±0.43),(2.74±0.65),(1.87±0.21) and (2.92±0.49) respectively.The protein levels of TLR4 were (1.00±0.17),(3.92±0.71),(2.77±0.54),(2.81±0.43),(2.06±0.28) and (3.11±0.44)respectively.The protein levels of myeloid differentiation factor 88 (MyD88) were (1.00±0.15),(2.94±0.45),(2.21±0.39),(2.25±0.23),(1.44±0.16) and (2.41±0.27) respectively.There were statistically significant differences in the above indicators (all P<0.05).Compared with the model group,the expressions of HtrA2,white blood cell counts,percentages of neutrophils,levels of inflammation and oxidative stress,and protein levels of the TLR signaling pathway in the doxycycline group and the levofloxacin group were all decreased.The combination group showed further improvement.Compared with the combination group,the results in the oe-HtrA2 group were the opposite.

Conclusion

The combination of doxycycline and levofloxacin can improve lung injury in rats with CRAB pneumonia,which may be related to the regulation of HtrA2 and the inhibition of the activation of the TLR2/4-MyD88 signaling pathway.

表1 每组大鼠肺组织HtrA2 mRNA 相对表达水平(±s
图1 免疫荧光检测大鼠肺组织HtrA2 表达
图2 大鼠肺组织病理形态(×100 倍,苏木素-伊红染色) A:对照组;B:模型组;C:多西环素组;D:左氧氟沙星组;E:联合组;F:oe-HtrA2 组
表2 每组大鼠肺组织鲍曼不动杆菌含量变化(±s
表3 每组大鼠外周血白细胞计数和中性粒细胞百分比变化(±s
表4 每组大鼠肺组织炎症因子水平(±s
表5 每组大鼠肺组织丙二醛水平和超氧化物歧化酶活性变化(±s
图3 2′,7′-二氯氢化荧光素二酯探针检测大鼠肺组织活性氧水平
表6 每组大鼠肺组织TLR2、TLR4 和myD88 蛋白相对水平(±s
图4 蛋白印迹法检测大鼠肺组织TLR2,TLR4 和myD88 蛋白水平 注:1 组为对照组;2 组为模型组;3 组为多西环素组;4 组为左氧氟沙星组;5 组为联合组;6 组为oe-HtrA2 组
1
陶 春,童 瑜,王 旗,等.耐碳青霉烯类鲍曼不动杆菌颅内感染多途径应用多黏菌素类药物治疗的病例分析[J].医药导报,2024,43(10): 1583-1588.
2
Tamma PD,Aitken SL,Bonomo RA,et al.Infectious diseases society of america guidance on the treatment of ampc β-lactamaseproducing enterobacterales,carbapenem-resistant acinetobacter baumannii,and Stenotrophomonas maltophilia Infections[J].Clin Infect Dis,2022,74(12): 2089-2114.
3
庞茜茜,刘 斐,蒲洁琨,等.两种联合用药方案治疗耐碳青霉烯类鲍曼不动杆菌肺炎的效果及对炎症反应的影响[J].中国医院用药评价与分析,2024,24(2): 176-179.
4
Zhang DF,Zhang ZF,Li PD,et al.Characterization of carbapenemresistant Acinetobacter baumannii ST540 and Klebsiella pneumoniae ST2237 isolates in a pneumonia case from China[J].J Appl Microbiol,2022,133(3): 1434-1445.
5
Franzone JP,Mackow NA,van Duin D.Current treatment options for pneumonia caused by carbapenem-resistant Acinetobacter baumannii[J].Curr Opin Infect Dis,2024,37(2): 137-143.
6
王月华,鞠晓红.棘阿米巴感染治疗药物的研究进展[J].医药导报,2023,42(9): 1363-1367.
7
吴 凡,王保贵,胡 文,等.多西环素联合左氧氟沙星对耐药肺炎克雷伯菌的体内外抗菌活性研究[J].中国新药杂志,2023,32(23): 2425-2433.
8
El-Ghali A,Kunz Coyne AJ,et al.Sulbactam-durlobactam:A novel β-lactam-β-lactamase inhibitor combination targeting carbapenemresistant Acinetobacter baumannii infections[J].Pharmacotherapy,2023,43(6): 502-513.
9
Wu L,Li X,Li Z,et al.HtrA serine proteases in cancers: A target of interest for cancer therapy[J].Biomed Pharmacother,2021,139: 111603.
10
杨 阳,任田田,徐 鹏.耐碳青霉烯类肺炎克雷伯菌感染治疗效果影响因素分析及预测模型建立[J/OL].现代疾病预防控制,2024,35(10): 726-731.
11
黄冬梅,刘 军,李福祥,等.四川省二级综合医院CRAB 感染发生的相关危险因素分析[J/CD].中华肺部疾病杂志(电子版),2020,13(3): 355-359.
12
晁晓峰,冯倚帆,黄天宁,等.颅脑术后继发颅内多重耐药鲍曼不动杆菌感染的危险因素[J].中国临床神经外科杂志,2022,27(6): 471-473.
13
段 炜,范沁林,刘 勇.替加环素对NICU 碳青霉烯耐药菌致院内获得性肺炎抗感染疗效的回顾性分析[J/CD].中华肺部疾病杂志(电子版),2019,12(3): 315-320.
14
Zha L,Zhang X,Cheng Y,et al.Intravenous Polymyxin b as adjunctive therapy to high-dose tigecycline for the treatment of nosocomial pneumonia due to carbapenem-resistant acinetobacter baumannii and klebsiella pneumoniae: a propensity score-matched cohort study[J].Antibiotics (Basel),2023,12(2): 273.
15
黄育波,周宇麒,郑文争,等.多重耐药鲍曼不动杆菌外排泵与外膜蛋白表达水平分析[J].实用医学杂志,2023,39(16):2122-2129.
16
Deng Y,Chen L,Yue M,et al.Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia[J].BMC Infect Dis,2022,22(1): 795.
17
罗 丹,李玉良,翁邦碧,等.鲍曼不动杆菌快速表型药敏检测方法的建立和初步应用[J].第三军医大学学报,2021,43(18): 1775-1782.
18
王保贵,王娜娜,周思绪,等.多西环素联合利福平对耐碳青霉烯类肺炎克雷伯菌体内外抗菌活性[J].中国抗生素杂志,2023,48(10): 1183-1191.
19
Sitovs A,Sartini I,Giorgi M.Levofloxacin in veterinary medicine:a literature review[J].Res Vet Sci,2021,137: 111-126.
20
Aslam HM,Sohail A,Shahid A,et al.Levofloxacin induces erythrocyte contraction leading to red cell death[J].Drug Target Insights,2024,18: 78-83.
21
陈苏维,艾雪言,刘 晔,等.盘基网柄菌基网柄菌HtrA2 基因的克隆与生物信息学分析[J].安康学院学报,2022,34(4):123-128.
22
Feng L,Li Z,Xiong Y,et al.HtrA2 independently predicts poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma[J].J Oncol,2023,4067418.
23
Tian Z,Zhao J,Wang Y.The prognostic value of TPM1-4 in hepatocellular carcinoma[J].Cancer Med,2022,11(2): 433-446.
24
柴 媛,王俊瑞,英 兰,等.BALB/c 大鼠多重耐药鲍曼不动杆菌肺部感染模型的建立和评估[J].微生物与感染,2022,17(2): 71-80.
25
张 阳,焦雨佼,巩翠珂,等.慢阻肺患者鲍曼不动杆菌感染肺泡巨噬细胞凋亡机制的研究[J].中国病原生物学杂志,2022,17(9): 1082-1085.
26
陶兴茹,段彦彦,董丽丽,等.左氧氟沙星和多西环素治疗儿童难治性支原体肺炎的安全性和有效性分析[J].中南药学,2021,19(5): 1025-1028.
27
Xu Z,Lin J,Xie Y,et al.HtrA2 is required for inflammatory responses in BMDMs via controlling TRAF2 stability in collageninduced arthritis[J].Mol Immunol,2021,129: 78-85.
28
何谷良,吴 涛,卢芳国,等.麻杏石甘汤对流感病毒肺部感染模型肺组织TLR2/4-MyD88 信号通路蛋白表达的影响[J].中华中医药杂志,2022,37(1): 435-440.
29
Gong Z,Zhang J,Zhang S,et al.TLR2,TLR4,and NLRP3 mediated the balance between host immune-driven resistance and tolerance in Staphylococcus aureus-infected mice [ J].Microb Pathog,2022,169: 105671.
30
严宝飞,戴仕林,刘圣金,等.黄芩汤对非酒精性脂肪肝炎大鼠的作用及机制研究[J].中国医院药学杂志,2022,42(10):1009-1014.
[1] 叶晨雨, 王臻, 牟珂, 袁鸣, 程雨欣, 杨勇. 肺部超声在儿童支原体肺炎中的应用价值初步研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(12): 1118-1123.
[2] 刘思锐, 赵辰阳, 张睿, 张一休, 杨萌. 多普勒超声对孕鼠子宫动脉不同节段血流动力学参数的评估[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 877-883.
[3] 王利军, 张红红, 龙春欢. 重症肺炎患者肠道微生物群落的宏基因组学研究及其对抗菌药物疗效的预测价值[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(06): 360-368.
[4] 黄庆, 雷俊杰, 潘家龙, 林冬云. 肺炎链球菌与EB病毒共感染儿童坏死性肺炎一例并文献复习[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(06): 377-383.
[5] 张胜伟, 孟召路, 热汗古丽·吾休尔, 万世森, 闫鹏, 阳乔. 肺炎支原体诱发反应性感染性皮疹黏膜疹一例[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 309-313.
[6] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[7] 朱苏徽, 鲍磊. 奥马环素联合丙种球蛋白治疗重症社区获得性肺炎的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(06): 953-956.
[8] 胡菊英, 李银华, 洪兰, 王宏勇, 丁先军, 李承美, 谭心海. 儿童感染大叶性肺炎与支气管肺炎临床特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 813-816.
[9] 晏彦, 杨军, 周凤兰, 孙登昆, 陈玉. 哌拉西林他唑巴坦和哌拉西林舒巴坦治疗细菌性肺炎的倾向性匹配分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 817-819.
[10] 邢嘉翌, 龚佳晟, 祝佳佳, 陆群. 肺癌化疗患者继发肺部感染的病原菌耐药性及炎症因子变化分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 714-718.
[11] 杨慧, 郭丽娟, 冯晓丹, 李静, 黄成谋, 蔡兴锐, 覃英娇, 王远礼. 非小细胞肺癌铂类药物耐药mi RNA表达特征及预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 719-724.
[12] 于燕兴, 梅喜庆, 刘凤娟, 于梓薇, 许亚慧, 徐飞. 高通量测序重症肺炎肺泡灌洗液病原体的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 785-788.
[13] 刘雯, 赵明栋, 夏伟, 潘以雄. 不同剂量比阿培南治疗重症肺炎的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 789-792.
[14] 刘春军, 严方方, 王宝锋, 常婷婷, 郭红红, 李志强. 替加环素联合人免疫球蛋白治疗XDRAB致VAP 的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 797-800.
[15] 赵鹏程, 陈彦, 董艳彬. 肺炎克雷伯菌肝脓肿患者发生侵袭综合征的危险因素分析[J/OL]. 中华卫生应急电子杂志, 2024, 10(06): 336-340.
阅读次数
全文


摘要